Cyclo Therapeutics, Inc. – NASDAQ:CYTHW

Cyclo Therapeutics stock price today

$0.032
-0.10
-77.14%
Financial Health
0
1
2
3
4
5
6
7
8
9

Cyclo Therapeutics stock price monthly change

-6.67%
month

Cyclo Therapeutics stock price quarterly change

-6.67%
quarter

Cyclo Therapeutics stock price yearly change

-50.00%
year

Cyclo Therapeutics key metrics

Market Cap
 21.74M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -1
Revenue
 1.12M
EBITDA
 -20.12M
Income
 -19.39M
Revenue Q/Q
 32.83%
Revenue Y/Y
 -15.51%
Profit margin
 -747.59%
Oper. margin
 -755.91%
Gross margin
 89.19%
EBIT margin
 -755.91%
EBITDA margin
 -1786.87%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Cyclo Therapeutics stock price history

Cyclo Therapeutics stock forecast

Cyclo Therapeutics financial statements

Profit Margin

Cyclo Therapeutics, Inc. (NASDAQ:CYTHW): Profit margin
Jun 2023 117.11K -4.63M -3958.79%
Sep 2023 495.47K -4.77M -962.98%
Dec 2023 311.39K -5.64M -1811.95%
Mar 2024 202.45K -4.34M -2145.25%
CYTHW income statement history

Debt to Assets

Cyclo Therapeutics, Inc. (NASDAQ:CYTHW): Debt to assets
Jun 2023 4642667 6.12M 131.98%
Sep 2023 5597066 6.64M 118.81%
Dec 2023 13247538 8.49M 64.09%
Mar 2024 7163890 6.55M 91.48%
CYTHW balance sheet history

Cash Flow

Cyclo Therapeutics, Inc. (NASDAQ:CYTHW): Cash Flow
Jun 2023 -3.47M 0 3.40M
Sep 2023 -4.04M 0 5.00M
Dec 2023 -4.29M -2.42K 11.74M
Mar 2024 -6.18M 0 -69.28K
CYTHW cash flow history

Cyclo Therapeutics alternative data

Cyclo Therapeutics
Employees

Cyclo Therapeutics, Inc. (NASDAQ:CYTHW): Employee count
Jan 2024 9
Feb 2024 9
Mar 2024 8
Apr 2024 8
May 2024 8
Jun 2024 8
Jul 2024 8

Cyclo Therapeutics other data

Cyclo Therapeutics
Insider Trading

Cyclo Therapeutics, Inc. (NASDAQ:CYTHW): Insider trades (number of shares)
Period Buy Sel
Oct 2021 1000 0
Nov 2021 15652 0
Dec 2021 29000 0
Jan 2022 12000 0
Feb 2022 10334 0
Mar 2022 10000 0
Apr 2022 2000 0
May 2022 8000 0
Sep 2022 5000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
OSTRONIC FRANCIS PATRICK director
 Common Stock 5,000 $1.76 $8,800
Purchase
OSTRONIC FRANCIS PATRICK director
 Common Stock 4,988 $2.04 $10,176
Purchase
OSTRONIC FRANCIS PATRICK director
 Common Stock 12 $2 $24
Purchase
TATE JEFFREY director, officer.. Common Stock 3,000 $2.12 $6,354
Purchase
TATE JEFFREY director, officer.. Common Stock 1,065 $2.71 $2,882
Purchase
TATE JEFFREY director, officer.. Common Stock 300 $2.7 $810
Purchase
TATE JEFFREY director, officer.. Common Stock 635 $2.5 $1,588
Purchase
SIEGER MARKUS director
 Common Stock 10,000 $2.73 $27,300
Purchase
FINE N SCOTT director, officer.. Common Stock 10,334 $3.58 $36,996
Purchase
OSTRONIC FRANCIS PATRICK director
 Common Stock 2,000 $3.75 $7,500
CYTHW insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Cyclo Therapeutics stock today?

    One share of Cyclo Therapeutics stock can currently be purchased for approximately $0.03.

  • When is Cyclo Therapeutics's next earnings date?

    Unfortunately, Cyclo Therapeutics's (CYTHW) next earnings date is currently unknown.

  • Does Cyclo Therapeutics pay dividends?

    No, Cyclo Therapeutics does not pay dividends.

  • How much money does Cyclo Therapeutics make?

    Cyclo Therapeutics has a market capitalization of 21.74M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 21.76% to 1.08M US dollars.

  • What is Cyclo Therapeutics's stock symbol?

    Cyclo Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "CYTHW".

  • What is Cyclo Therapeutics's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Cyclo Therapeutics?

    Shares of Cyclo Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Cyclo Therapeutics have?

    As Jul 2024, Cyclo Therapeutics employs 8 workers.

  • When Cyclo Therapeutics went public?

    Cyclo Therapeutics, Inc. is publicly traded company for more then 4 years since IPO on 18 Dec 2020.

  • What is Cyclo Therapeutics's official website?

    The official website for Cyclo Therapeutics is cyclotherapeutics.com.

Cyclo Therapeutics company profile:

Cyclo Therapeutics, Inc.

cyclotherapeutics.com
Exchange:

NASDAQ

Full time employees:

8

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.


,

CIK: 0000922247
ISIN: US23254X1101
CUSIP: 23254X110